Pages that link to "Q27011510"

The following pages link to Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications (Q27011510):

Displaying 12 items.

• Adoptive T-Cell Immunotherapy (Q26782845) (← links)
• Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? (Q30411008) (← links)
• Immunological deregulation in classic hodgkin lymphoma. (Q33778391) (← links)
• Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies (Q33886267) (← links)
• Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis (Q36278227) (← links)
• Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. (Q38889427) (← links)
• Mechanisms underlying the association between obesity and Hodgkin lymphoma (Q38910560) (← links)
• Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature review (Q39416431) (← links)
• Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma (Q40042049) (← links)
• Guillain-Barré syndrome and severe infection following chemotherapy for peripheral T-cell lymphoma: A case report (Q41682425) (← links)
• Plasmacytoid dendritic cell and CD4 + T cell deficiencies in untreated Hodgkin disease: implications for susceptibility to opportunistic infections (Q43465744) (← links)
• Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It. (Q64983758) (← links)